{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:19:35Z","timestamp":1776838775472,"version":"3.51.2"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.urolonc.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,3,28]],"date-time":"2017-03-28T21:16:50Z","timestamp":1490735810000},"page":"531.e9-531.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Disparity between pre-existing management of penile cancer and NCCN guidelines"],"prefix":"10.1016","volume":"35","author":[{"given":"Rebecca A.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily A.","family":"Slopnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth K.","family":"Ferry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0769-6026","authenticated-orcid":false,"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon P.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Abouassaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.urolonc.2006.08.029","article-title":"Incidence trends in primary malignant penile cancer","volume":"25","author":"Barnholtz-Sloan","year":"2007","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/s40064-015-1191-4","article-title":"Trends in penile cancer: a comparative study between Australia, England and Wales, and the US","volume":"4","author":"Sewell","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.urolonc.2017.03.002_bib3","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.urology.2016.06.048","article-title":"Racial disparities differ for African Americans and Hispanics in the diagnosis and treatment of penile cancer","volume":"96","author":"Slopnick","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.juro.2012.05.012","article-title":"Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control","volume":"188","author":"Philippou","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.juro.2011.05.084","article-title":"Long-term outcome of excisional organ sparing surgery for carcinoma of the penis","volume":"186","author":"Feldman","year":"2011","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.juro.2006.03.063","article-title":"Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence","volume":"176","author":"Lont","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.eururo.2007.02.038","article-title":"Reconstructive surgery for invasive squamous carcinoma of the glans penis","volume":"52","author":"Smith","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1111\/j.1464-410X.2012.11084.x","article-title":"Organ-preserving surgery for penile cancer: description of techniques and surgical outcomes","volume":"110","author":"Veeratterapillay","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1464-410x.2000.00413.x","article-title":"The histological extent of the local spread of carcinoma of the penis and its therapeutic implications","volume":"85","author":"Agrawal","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/sm2.56","article-title":"Outcomes for organ-preserving surgery for penile cancer","volume":"3","author":"Scarberry","year":"2015","journal-title":"Sex Med"},{"key":"10.1016\/j.urolonc.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.urology.2011.08.006","article-title":"Organ-sparing surgery for penile cancer: complications and outcomes","volume":"78","author":"Li","year":"2011","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"594","DOI":"10.6004\/jnccn.2013.0075","article-title":"Penile cancer: clinical practice guidelines in oncology","volume":"11","author":"Clark","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.urolonc.2017.03.002_bib14","unstructured":"NCCN Guidelines: Penile Cancer, Version 1.2016. 2016. https:\/\/www.nccn.org\/; 2016 [accessed 16.05.16]."},{"key":"10.1016\/j.urolonc.2017.03.002_bib15","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.urolonc.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/iju.12759","article-title":"Prognostic factors in patients with penile carcinoma and inguinal lymph node metastasis","volume":"22","author":"da Costa","year":"2015","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.juro.2013.07.088","article-title":"Contemporary management of regional nodes in penile cancer-improvement of survival?","volume":"191","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/01.ju.0000154565.37397.4d","article-title":"Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases","volume":"173","author":"Kroon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/01.ju.0000081201.40365.75","article-title":"Management of clinically node negative penile carcinoma: improved survival after the introduction of dynamic sentinel node biopsy","volume":"170","author":"Lont","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00345-015-1593-5","article-title":"Extent of pelvic lymph node dissection in penile cancer may impact survival","volume":"34","author":"Zargar-Shoshtari","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1159\/000354401","article-title":"Population-based assessment of the number of lymph nodes removed in the treatment of penile squamous cell carcinoma","volume":"92","author":"Zhu","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.urolonc.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.urology.2014.11.048","article-title":"Oncologic outcomes of penile cancer treatment at a UK supraregional center","volume":"85","author":"Veeratterapillay","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3892\/ol.2015.3221","article-title":"Surgical treatment of primary disease for penile squamous cell carcinoma: a Surveillance, Epidemiology, and End Results database analysis","volume":"10","author":"Zhu","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/j.urolonc.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/bju.12993","article-title":"Swedish National Penile Cancer Register: incidence, tumour characteristics, management and survival","volume":"117","author":"Kirrander","year":"2016","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.juro.2013.12.038","article-title":"Penile sparing surgery for penile cancer-does it affect survival?","volume":"192","author":"Djajadiningrat","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.urolonc.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.urology.2010.04.008","article-title":"Prognostic factors in penile cancer","volume":"76","author":"Ficarra","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.urolonc.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.urology.2015.12.058","article-title":"Centralization of penile cancer management in the United States: a combined analysis of the American Board of Urology and National Cancer Data Base","volume":"90","author":"Matulewicz","year":"2016","journal-title":"Urology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917301023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143917301023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:11:30Z","timestamp":1761041490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143917301023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1078143917301023"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.03.002","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparity between pre-existing management of penile cancer and NCCN guidelines","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}